Clinical trials
Active, not recruiting Phase 2 Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 9 |
| National Cancer Institute (NCI) | 6 |
| Emory University | 2 |
| Hoffmann-La Roche | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Bradley A. McGregor, MD | 1 |
| Dana-Farber Cancer Institute | 1 |
| Dong Wen | 1 |
| ImmunityBio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 41 |
| Kidney Neoplasms | 8 |
| Melanoma | 8 |
| Carcinoma, Hepatocellular | 5 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Sarcoma | 4 |
| Carcinoma, Transitional Cell | 3 |
| Colorectal Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Neoplasms, Unknown Primary | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.